Untreated low-grade ductal carcinoma in situ poses long-term risk

Ductal carcinoma in situ (DCIS) of the breast develops into invasive breast cancer (IBC) in approximately 50 percent of women if left untreated, with the risk extending over more than forty years, according to a new study appearing in the June 15, 2005 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society. The study, a four-decade long follow-up of women with low-grade DCIS treated by biopsy alone from 1950-1968, reveals the natural history of this poorly understood breast cancer and supports curative treatment by surgical excision.

In the decades prior to mammographic screening, DCIS--presented as breast lump--was recognized microscopically by its high-grade features similar to invasive cancer, and represented only a small subset of all breast cancers. Small low-grade DCIS lesions simply were not recognized and were thus diagnosed as benign. Over the next 20-30 years, as criteria for diagnosis of DCIS were redefined, DCIS has gradually been recognized as spectrum of disease varying considerably in grade and extent. However, important differences in the clinical course of low- and high-grade disease have not always been appreciated. In addition, the distinction between low-grade and DCIS and the histologically similar but lesser lesions of atypical ductal hyperplasia (ADH) is critical as ADH lesions pose only small malignancy risk and predict risk to both breasts rather than regional risk. With the advent of mammography, DCIS is now identified earlier and is the largest growing subset of breast cancers. Understanding the natural history of low-grade DCIS can provide insight into current and future treatment strategies.

Led by Melinda E. Sanders, M.D. and David L. Page, M.D. of the Vanderbilt University Medical Center in Nashville, researchers followed the course of 28 women treated by biopsy only in the 1950s and 1960

Contact: David Greenberg
John Wiley & Sons, Inc.

Page: 1 2

Related medicine news :

1. Long-term outcomes promising for patients with localized, low-grade prostate cancer
2. Correlation between bile duct obstruction and ductal cancer found
3. Lobular breast cancer can be managed as ductal cancer
4. GSKs Pazopanib shows positive results in patients with advanced renal cell carcinoma
5. Doctors conclude temsirolimus is effective new treatment for advanced renal cell carcinoma
6. Aspirin might prevent development of oesophageal adenocarcinoma
7. Mayor of New York proposes preventing 100 million deaths from tobacco
8. HIVMA opposes The Gambias unproven AIDS remedy
9. Swishing once a day with mouthrinse poses no harm to dental work
10. Elders death at airstrip: Research exposes deeper issues
11. Stalking poses serious public health problem

Post Your Comments:

(Date:2/21/2020)... CHICAGO (PRWEB) , ... February 21, 2020 , ... ... selected to host the 2021 World Cancer Leaders’ Summit in Boston, MA, in ... (UICC)—annually brings together key decision makers including prime ministers, ministers of health, city ...
(Date:2/20/2020)... ... ... R3 Medical Training announced its next joint injection training courses scheduled for ... for all large and small joints along with ultrasound needle guidance. , Performing joint ... is to perform injections in a supervised setting. R3 Medical Training's joint injection ...
(Date:2/20/2020)... ... ... Millennial women are flocking to cosmetic surgeons like Dr. Richard E. Buckley ... achieve “ Rich Girl Face .” In fact, Glamour magazine called it the cosmetic ... It’s a look inspired by the signature bee-stung lips, smooth skin, lifted eyebrows and ...
(Date:2/19/2020)... , ... February 19, 2020 , ... ... with a grant of $10,000.00 from the Doug Flutie, Jr. Foundation for Autism. ... for students with autism. , The physical fitness program will include the hiring ...
(Date:2/19/2020)... ... February 19, 2020 , ... The ... deadline for its new Lifestyle Medicine Residency Curriculum (LMRC). The curriculum is the ... medical residency programs. Driven by resident involvement, the curriculum has included residents ...
Breaking Medicine News(10 mins):
(Date:2/15/2020)... ... February 14, 2020 , ... Dr. Ray Lopez, renowned foot ... Network. , The Haute Beauty Network, well known for its exclusive and luxurious lifestyle ... ankle and our newest addition to the Haute Beauty members-only network. , Haute Beauty ...
(Date:2/14/2020)... ... 2020 , ... Dignitana AB , world leader in scalp cooling innovation, ... sponsor three signature events in 2020 with Susan G. Komen®. The sponsorship extends Dignitana’s ... the Cure® and MORE THAN PINK Walk® events in key Dignitana markets throughout year. ...
(Date:2/14/2020)... ... 14, 2020 , ... Top Customs and FDA Enforcement Issues ... Feb. 25, 2020, 1:30 p.m.-3:00 p.m. EST, https://www.fdanews.com/customsfdaenforcement , What is ... not know the latest one can become vulnerable to having shipments delayed, detained ...
Breaking Medicine Technology:
Cached News: